HHS: 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
Sep 29, 2017
Final rule from the U.S. Department of Health and Human Services (HHS) establishing July 1, 2018, as the effective date for a January 5, 2017, rule which sets forth calculation of the ceiling price and application of civil monetary penalties for drug manufacturers participating in the 340B Drug Pricing Program. HHS chose July 1, 2018, after careful consideration of public comments, and to allow regulated entities sufficient time to comply with the new requirements.
Legislation and regulations · Pharmacy and prescription drugs